Gyre Therapeutics Acquires Cullgen in $300 Million All-Stock Transaction

Gibson, Dunn & Crutcher LLP has advised Gyre Therapeutics, and Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. has advised Cullgen Inc. Gyre Therapeutics, Inc., an…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here